BridgeMD
New treatment option for Papillary Thyroid Cancer
Official title A Clinical Study on the Benefits of Carbon Nanoparticles Injection Time in Patients With Thyroid Cancer.
ClinicalTrials.gov ID: NCT06791005
What this study is testing
What is Preoperative Injection of Carbon Nanoparticles?
Preoperative Injection of Carbon Nanoparticles is an investigational medicine, given as an injectable medicine, being studied as a potential treatment for papillary thyroid cancer.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The detection rate of thyroid cancer (PTC) has increased rapidly in recent years. Except undifferentiated cancer, surgery is still one of the most important treatments for all types of thyroid cancer, and there is a consensus to use the lobes of the gland as the minimum extent of resection.
- Phase 3: a large, late-stage study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 16 to 80
You may be able to join if
- Preoperative pathological assessment indicated the presence of thyroid cancer with a maximum diameter of less than 4 cm.
- Postoperative pathological evaluation confirmed bilateral thyroid cancer or lateral lymph node metastasis.
- Vocal cord examination conducted one week prior to surgery revealed no abnormalities.
- The patient had no history of prior thyroid surgery and required a total thyroidectomy.
- Blood pressure was stably controlled.
You likely can't join if
- Prior to enrollment, the patient had received radiotherapy, chemotherapy, or isotope therapy.
- A documented history of thyroid surgery.
- Age under 16 years.
- Known allergies to the medications under investigation or an inability to tolerate surgical intervention.
- Presence of a retrosternal thyroid tumor.
- Tumor invasion of the parathyroid glands and/or the recurrent laryngeal nerve during surgical procedures.
See the full eligibility criteria
- Preoperative pathological assessment indicated the presence of thyroid cancer with a maximum diameter of less than 4 cm.
- Postoperative pathological evaluation confirmed bilateral thyroid cancer or lateral lymph node metastasis.
- Vocal cord examination conducted one week prior to surgery revealed no abnormalities.
- The patient had no history of prior thyroid surgery and required a total thyroidectomy.
- Blood pressure was stably controlled.
- The patient regained consciousness and was able to communicate normally.
- Prior to enrollment, the patient had received radiotherapy, chemotherapy, or isotope therapy.
- A documented history of thyroid surgery.
- Age under 16 years.
- Known allergies to the medications under investigation or an inability to tolerate surgical intervention.
- Presence of a retrosternal thyroid tumor.
- Tumor invasion of the parathyroid glands and/or the recurrent laryngeal nerve during surgical procedures.
- Postoperative pathology suggestive of medullary carcinoma or undifferentiated carcinoma.
- Development of a postoperative tracheal fistula.
The study team makes the final eligibility decision.
Where it's taking place
- Xi'an, Shaanxi, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 16 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Xi'an, Shaanxi, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.